Wildhagen MF - Search Results

1

Incidence and follow-up of patients with focal prostate carcinoma in 2 screening rounds after an interval of 4 years.

Postma R, de Vries SH, Roobol MJ, Wildhagen MF, Schröder FH, van der Kwast TH. Postma R, et al. Among authors: wildhagen mf. Cancer. 2005 Feb 15;103(4):708-16. doi: 10.1002/cncr.20840. Cancer. 2005. PMID: 15648082 Free article.

2

Prostate-specific antigen change in the European Randomized Study of Screening for Prostate Cancer, section Rotterdam.

Raaijmakers R, Wildhagen MF, Ito K, Pàez A, de Vries SH, Roobol MJ, Schröder FH. Raaijmakers R, et al. Among authors: wildhagen mf. Urology. 2004 Feb;63(2):316-20. doi: 10.1016/j.urology.2003.09.028. Urology. 2004. PMID: 14972481

3

Prostate cancer detection in the prostate specific antigen range of 2.0 to 3.9 ng/ml: value of percent free prostate specific antigen on tumor detection and tumor aggressiveness.

Raaijmakers R, Blijenberg BG, Finlay JA, Rittenhouse HG, Wildhagen MF, Roobol MJ, Schröder FH. Raaijmakers R, et al. Among authors: wildhagen mf. J Urol. 2004 Jun;171(6 Pt 1):2245-9. doi: 10.1097/01.ju.0000127731.56103.50. J Urol. 2004. PMID: 15126795

4

Comparison of screen detected and clinically diagnosed prostate cancer in the European randomized study of screening for prostate cancer, section rotterdam.

van der Cruijsen-Koeter IW, Vis AN, Roobol MJ, Wildhagen MF, de Koning HJ, van der Kwast TH, Schröder FH. van der Cruijsen-Koeter IW, et al. Among authors: wildhagen mf. J Urol. 2005 Jul;174(1):121-5. doi: 10.1097/01.ju.0000162061.40533.0f. J Urol. 2005. PMID: 15947595 Clinical Trial.

5

Digital rectal examination is no longer necessary in the routine follow-up of men with undetectable prostate specific antigen after radical prostatectomy: the implications for follow-up.

Chaplin BJ, Wildhagen MF, Schroder FH, Kirkels WJ, Bangma CH. Chaplin BJ, et al. Among authors: wildhagen mf. Eur Urol. 2005 Dec;48(6):906-10. doi: 10.1016/j.eururo.2005.07.006. Epub 2005 Aug 2. Eur Urol. 2005. PMID: 16126322

6

Randomized, double-blind, placebo-controlled crossover study in men with prostate cancer and rising PSA: effectiveness of a dietary supplement.

Schröder FH, Roobol MJ, Boevé ER, de Mutsert R, Zuijdgeest-van Leeuwen SD, Kersten I, Wildhagen MF, van Helvoort A. Schröder FH, et al. Among authors: wildhagen mf. Eur Urol. 2005 Dec;48(6):922-30; discussion 930-1. doi: 10.1016/j.eururo.2005.08.005. Epub 2005 Oct 17. Eur Urol. 2005. PMID: 16263208 Clinical Trial.

7

Tumor characteristics and prognostic factors in two subsequent screening rounds with four-year interval within prostate cancer screening trial, ERSPC Rotterdam.

van der Cruijsen-Koeter IW, Roobol MJ, Wildhagen MF, van der Kwast TH, Kirkels WJ, Schröder FH. van der Cruijsen-Koeter IW, et al. Among authors: wildhagen mf. Urology. 2006 Sep;68(3):615-20. doi: 10.1016/j.urology.2006.03.015. Urology. 2006. PMID: 17010732 Clinical Trial.

8

ERG immunohistochemistry is not predictive for PSA recurrence, local recurrence or overall survival after radical prostatectomy for prostate cancer.

Hoogland AM, Jenster G, van Weerden WM, Trapman J, van der Kwast T, Roobol MJ, Schröder FH, Wildhagen MF, van Leenders GJ. Hoogland AM, et al. Among authors: wildhagen mf. Mod Pathol. 2012 Mar;25(3):471-9. doi: 10.1038/modpathol.2011.176. Epub 2011 Nov 11. Mod Pathol. 2012. PMID: 22080055 Free article.

9

Circulating free insulin-like growth factor (IGF)-I, total IGF-I, and IGF binding protein-3 levels do not predict the future risk to develop prostate cancer: results of a case-control study involving 201 patients within a population-based screening with a 4-year interval.

Janssen JA, Wildhagen MF, Ito K, Blijenberg BG, Van Schaik RH, Roobol MJ, Pols HA, Lamberts SW, Schröder FH. Janssen JA, et al. Among authors: wildhagen mf. J Clin Endocrinol Metab. 2004 Sep;89(9):4391-6. doi: 10.1210/jc.2004-0232. J Clin Endocrinol Metab. 2004. PMID: 15356036

10

Screening and prostate-cancer mortality in a randomized European study.

Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, Denis LJ, Recker F, Berenguer A, Määttänen L, Bangma CH, Aus G, Villers A, Rebillard X, van der Kwast T, Blijenberg BG, Moss SM, de Koning HJ, Auvinen A; ERSPC Investigators. Schröder FH, et al. N Engl J Med. 2009 Mar 26;360(13):1320-8. doi: 10.1056/NEJMoa0810084. Epub 2009 Mar 18. N Engl J Med. 2009. PMID: 19297566 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

84 results

Search Page